Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06137339 · ClinicalTrials.gov registry record · NA

AvoCog - the Effect of Daily Avocado Intake on Cognitive Function in Older Adults

A NA study of Brain Aging, sponsored by University of Kansas Medical Center.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT06137339 is a NA study of Brain Aging that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 70 participants, below the 256-participant average among 3 other Brain Aging trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06137339, a NA study of Brain Aging, is actively recruiting participants, sponsored by University of Kansas Medical Center.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to determine if adding avocados to the diet of impacts cognition in 70 older adults, age 65-85, without dementia. We will test for change in functional MRI, cognitive performance, and brain blood flow. Intervention group participants will be asked to consume 1 avocado per day for 12 weeks. Participants in the control group will be asked to continue their normal intake for 12 weeks. Throughout the study, participants will be asked to perform cognitive tests, MRI, blood tests, and questionnaires.

Conditions Studied

Interventions

  • OTHER Avocado Group

Study Locations (1)

Kansas

  • University of Kansas Medical Center - Kansas City

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2024-04-09
Est. Completion 2025-12
Phase NA

Sponsor

University of Kansas Medical Center

408 total trials

What the Registry Record Tells You About NCT06137339

The ClinicalTrials.gov registry entry for NCT06137339 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 256-participant average among 3 other Brain Aging trials with a reported enrollment target (73% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Brain Aging appearing as the primary indexed condition, and to 1 intervention - of which Avocado Group is the first listed.

NCT06137339 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT06137339 about?

NCT06137339 is a clinical study titled "AvoCog - the Effect of Daily Avocado Intake on Cognitive Function in Older Adults". The goal of this clinical trial is to determine if adding avocados to the diet of impacts cognition in 70 older adults, age 65-85, without dementia. We will test for change in functional MRI, cognitive performance, and brain blood flow. Intervention group participants will be asked to consume 1 avoc...

What is the current status of trial NCT06137339?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2024-04-09. Estimated completion is 2025-12.

What conditions does trial NCT06137339 study?

This clinical trial studies the following conditions: Brain Aging.

What interventions are being tested in trial NCT06137339?

The interventions under investigation include: Avocado Group (OTHER).

Who is sponsoring clinical trial NCT06137339?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06137339 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Brain Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.